Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Agusti Alentorn

Showing results (11-20 of 66) with videos related to

Pageof 7
Sort By:
Presse Medicale (Paris, France : 1983)|July 14, 2012
[Genetics and brain gliomas]Agusti Alentorn, Marianne Labussière, Marc Sanson, et al.
Expert Review of Anticancer Therapy|June 30, 2015
Molecular profiling of gliomas: potential therapeutic implicationsAgusti Alentorn, Alberto Duran-Peña, Sandeep C Pingle, et al.
International Journal of Molecular Sciences|May 28, 2020
Neurological Syndromes Associated with Anti-GAD AntibodiesMaëlle Dade, Giulia Berzero, Cristina Izquierdo, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|January 13, 2022
Expression and Prognostic Value of CD80 and CD86 in the Tumor Microenvironment of Newly Diagnosed GlioblastomaMohammed H Ahmed, Isaias Hernández-Verdin, Franck Bielle, et al.
International Journal of Molecular Sciences|October 13, 2021
Heterogeneity of Response to Iron-Based Metallodrugs in Glioblastoma Is Associated with Differences in Chemical Structures and Driven by FAS Expression Dynamics and Transcriptomic SubtypesAnne Vessières, Emie Quissac, Nolwenn Lemaire, et al.
Neuroimage. Clinical|September 26, 2021
Quantitative brain imaging analysis of neurological syndromes associated with anti-GAD antibodiesMaëlle Dade, Marine Giry, Giulia Berzero, et al.
Journal of Neuro-Oncology|May 27, 2025
Clinical and radiological features of pseudoprogression in brain tumors treated with immune checkpoint inhibitorsMaria José Ibáñez-Juliá, Luis Bataller, Francisco Javier Cabello-Murgui, et al.
The Oncologist|March 15, 2019
Pretreatment Hemoglobin as an Independent Prognostic Factor in Primary Central Nervous System LymphomasMy Le, Ytel Garcilazo, Maria-José Ibáñez-Juliá, et al.
Journal of Neuro-Oncology|November 27, 2015
TERT promoter mutations and rs2853669 polymorphism: prognostic impact and interactions with common alterations in glioblastomasUmberto Nencha, Amithys Rahimian, Marine Giry, et al.
Clinical Neurology and Neurosurgery|November 10, 2017
Brain volumetric analysis and cortical thickness in adults with saccadic intrusions (ocular flutter or opsoclonus-myoclonus syndrome)María-José Ibáñez-Juliá, Evangelia Pappa, Bertrand Gaymard, et al.
Pageof 7

Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
Presse Medicale (Paris, France : 1983)|July 14, 2012
[Genetics and brain gliomas]Agusti Alentorn, Marianne Labussière, Marc Sanson, et al.
Expert Review of Anticancer Therapy|June 30, 2015
Molecular profiling of gliomas: potential therapeutic implicationsAgusti Alentorn, Alberto Duran-Peña, Sandeep C Pingle, et al.
International Journal of Molecular Sciences|May 28, 2020
Neurological Syndromes Associated with Anti-GAD AntibodiesMaëlle Dade, Giulia Berzero, Cristina Izquierdo, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|January 13, 2022
Expression and Prognostic Value of CD80 and CD86 in the Tumor Microenvironment of Newly Diagnosed GlioblastomaMohammed H Ahmed, Isaias Hernández-Verdin, Franck Bielle, et al.
International Journal of Molecular Sciences|October 13, 2021
Heterogeneity of Response to Iron-Based Metallodrugs in Glioblastoma Is Associated with Differences in Chemical Structures and Driven by FAS Expression Dynamics and Transcriptomic SubtypesAnne Vessières, Emie Quissac, Nolwenn Lemaire, et al.
Neuroimage. Clinical|September 26, 2021
Quantitative brain imaging analysis of neurological syndromes associated with anti-GAD antibodiesMaëlle Dade, Marine Giry, Giulia Berzero, et al.
Journal of Neuro-Oncology|May 27, 2025
Clinical and radiological features of pseudoprogression in brain tumors treated with immune checkpoint inhibitorsMaria José Ibáñez-Juliá, Luis Bataller, Francisco Javier Cabello-Murgui, et al.
The Oncologist|March 15, 2019
Pretreatment Hemoglobin as an Independent Prognostic Factor in Primary Central Nervous System LymphomasMy Le, Ytel Garcilazo, Maria-José Ibáñez-Juliá, et al.
Journal of Neuro-Oncology|November 27, 2015
TERT promoter mutations and rs2853669 polymorphism: prognostic impact and interactions with common alterations in glioblastomasUmberto Nencha, Amithys Rahimian, Marine Giry, et al.
Clinical Neurology and Neurosurgery|November 10, 2017
Brain volumetric analysis and cortical thickness in adults with saccadic intrusions (ocular flutter or opsoclonus-myoclonus syndrome)María-José Ibáñez-Juliá, Evangelia Pappa, Bertrand Gaymard, et al.
Pageof 7